The Medicines and Healthcare products Regulatory Agency (MHRA) and the Drug Information Association (DIA) announced on 30 September 2026 the speaker line-up for their inaugural DIA-MHRA Global Summit. The two-day event was planned for 16 and 17 November 2026 in London, alongside activities for London Life Sciences Week.

According to the announcement, representatives from organisations including the US Food and Drug Administration, India's Central Drugs Standard Control Organisation, Swissmedic, Australia's Therapeutic Goods Administration, Microsoft, GSK, AstraZeneca, IQVIA, BioNTech, NICE and Duchenne UK were due to take part. The programme, under the theme "Global Collaboration for Safer and Smarter Health Innovation", was to cover regulatory innovation, advanced therapies, artificial intelligence, health data, patient access, rare diseases and international regulatory cooperation.

The organisers said attendees would also receive early insight into a series of MHRA announcements on its regulatory science and innovation ambitions. Tickets were on sale at the time of the announcement.